Immunitor Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Immunitor General Information

Description

Manufacturer and developer of immunotherapies and therapeutic vaccines intended for the treatment of tuberculosis. The company is engaged in the development and manufacturing of oral vaccines for human immunodeficiency virus, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial, cancer, obesity, and fungal infections, thereby enabling its clients to avail immunotherapies for a number of serious diseases affecting the world.

Contact Information

Website
www.immunitor.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2906 West Broadway
  • Suite 365
  • Vancouver, British Columbia
  • Canada
+1 (360)
Primary Industry
Pharmaceuticals
Parent Company
Immune Network
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 2906 West Broadway
  • Suite 365
  • Vancouver, British Columbia
  • Canada
+1 (360)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunitor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunitor‘s full profile, request access.

Request a free trial

Immunitor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer and developer of immunotherapies and therapeutic vaccines intended for the treatment of tuberculosis. The c
Pharmaceuticals
Vancouver, Canada

Pasadena, CA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immunitor Competitors (10)

One of Immunitor’s 10 competitors is Arrowhead Pharmaceuticals, a Corporation company based in Pasadena, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arrowhead Pharmaceuticals Corporation Pasadena, CA
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
Regulus Therapeutics Formerly VC-backed San Diego, CA
Ability Pharma Private Equity-Backed Barcelona, Spain
You’re viewing 5 of 10 competitors. Get the full list »

Immunitor FAQs

  • When was Immunitor founded?

    Immunitor was founded in 2000.

  • Where is Immunitor headquartered?

    Immunitor is headquartered in Vancouver, Canada.

  • What industry is Immunitor in?

    Immunitor’s primary industry is Pharmaceuticals.

  • Is Immunitor a private or public company?

    Immunitor is a Private company.

  • What is the current valuation of Immunitor?

    The current valuation of Immunitor is .

  • What is Immunitor’s current revenue?

    The current revenue for Immunitor is .

  • Who are Immunitor’s competitors?

    Arrowhead Pharmaceuticals, Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Regulus Therapeutics, and Ability Pharma are some of the 10 competitors of Immunitor.

  • When was Immunitor acquired?

    Immunitor was acquired on 14-Feb-2011.

  • Who acquired Immunitor?

    Immunitor was acquired by Immune Network.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »